Jim Simons Night Hawk Biosciences, Inc. Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.15 - $0.45 $42,493 - $127,481	283,293 Added 262.13%	391,366 $63,000
Q4 2023 Feb 13, 2024	BUY	$0.26 - $0.51 $5,564 - $10,914	21,400 Added 24.69%	108,073 $48,000
Q3 2023 Nov 14, 2023	BUY	$0.5 - $0.72 $7,800 - $11,232	15,600 Added 21.95%	86,673 $46,000
Q2 2023 Aug 11, 2023	BUY	$0.62 - $0.87 $18,476 - $25,926	29,800 Added 72.2%	71,073 $48,000
Q1 2023 May 12, 2023	BUY	$0.83 - $1.24 $10,126 - $15,128	12,200 Added 41.96%	41,273 $36,000
Q4 2022 Feb 13, 2023	BUY	$0.77 - $1.62 $6,699 - $14,094	8,700 Added 42.7%	29,073 $23,000
Q3 2022 Nov 14, 2022	BUY	$1.79 - $2.96 $9,359 - $15,477	5,229 Added 34.53%	20,373 $35,000
Q2 2022 Aug 12, 2022	SELL	$1.65 - $3.13 $61,790 - $117,215	-37,449 Reduced 71.21%	15,144 $39,000
Q1 2022 May 13, 2022	SELL	$2.1 - $3.54 $123,561 - $208,290	-58,839 Reduced 52.8%	52,593 $161,000
Q4 2021 Feb 11, 2022	BUY	$3.04 - $6.01 $338,753 - $669,706	111,432 New	111,432 $339,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.